# Dose-Finding of Retinoid 9cUAB30 in Healthy Volunteers

> **NCT01336387** · PHASE1 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 50 (actual)

## Conditions studied

- Healthy, no Evidence of Disease

## Interventions

- **DRUG:** retinoid 9cUAB30
- **OTHER:** placebo
- **OTHER:** pharmacological study
- **OTHER:** laboratory biomarker analysis
- **OTHER:** cancer prevention

## Key facts

- **NCT ID:** NCT01336387
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01336387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01336387, "Dose-Finding of Retinoid 9cUAB30 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01336387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*